Get full access to one story every week, and to summaries of all other stories. Just create a free account

GPT-4, the latest iteration of ChatGPT—the artificial-intelligence (AI) tool designed to “converse” with humans through text and images—is dropping anchor in India. The stakes are getting higher: not only for its Big Tech patron Microsoft but also for the enterprises in the country. And the cloud businesses of Amazon—the market leader—as well as Google are at risk.

As businesses, from conglomerates to upstarts, grapple with the question of how to adapt to generative AI—a type of AI algorithm that generates new content based on existing data—the tech giants are stepping up to help. Currently, Satya Nadella-led Microsoft is leading the charge, having invested invested TechCrunch Microsoft invests billions more dollars in OpenAI, extends partnership Read more billions of dollars in OpenAI, the creator of ChatGPT and other viral AI tools such as Dall-E.

Driven by a fear of missing out, big guns of Indian commerce—Reliance Industries, Adani Group, Tata Group, and Aditya Birla Group—are vying for a piece of the action. Even startups like Cred, a fintech valued at US$6.4 billion, have thrown their hat in the ring. Some are already undertaking proofs of concept (PoC) proofs of concept (PoC) Proofs of concept Proof of concept is a realisation of a certain method or idea in order to demonstrate its feasibility. to gain an edge.

This generative AI technology first took the world by storm in November. GPT-4, the latest version developed after experiments with chatbot-like functionalities, promises to help businesses transform their operations. 

To the point that even a long-standing pharmaceutical giant like Dr Reddy’s Laboratories is exploring its potential, The Ken has learnt.

The Pharma company, which will post ~US$3.3 billion in revenues in the year ended March, annually launches 10-50 products across the US, Europe, and Asia. It’s a daunting process that includes submitting a detailed dossier to regulatory agencies such as the US Food and Drug Administration (FDA) or the Drugs Controller General of India (DCGI). With GPT-4, the pharma company hopes to reduce the time it takes to prepare and file dossiers.

GPT-4, thanks to its capability advancements, is helping Microsoft take on the current #1 in India, Amazon Web Services Amazon Web Services The Ken AWS, Microsoft and the race to turn Big Gov into big business Read more (AWS), and get further ahead of the distant #3, Google Cloud Platform (GCP), in the cloud war cloud war The Ken Google India poaches big from AWS for US$1B cloud revenue dream Read more .

AUTHOR

Pratap Vikram Singh

Pratap is based out of Delhi and covers policy and myriad intersections with the other sectors, most notably technology. He has worked with Governance Now for seven years, reporting on technology, telecom policy, and the social sector.

View Full Profile

Read this story. Subscribe Now

This story is available across both editions. Subscribe to the one that’s most relevant for you. Questions?

 

Premium

  • 5 original and reported longform business stories every week
  • Access to ONLY India edition
  • Close to 250 exclusive stories every year
  • Full access to over 6 years of paywalled stories
  • Pick up to 5 premium subscriber newsletters
  • 4 original and reported longform business stories each week
  • Access to ONLY Southeast Asia edition
  • Close to 200 exclusive stories every year
  • Full access to all paywalled stories since March 2020
  • Pick up to 5 premium subscriber newsletters

Rs. 2,750 /year

$ 120 /year

India Edition
Subscribe Subscribe
Most Asked For

Borderless

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories

Rs. 4,200 /year

Subscribe
 

Echelon

  • 8 original and reported longform business stories each week
  • Access to both India and Southeast Asia editions
  • Close to 400 exclusive stories every year
  • Full access to over 6 years of paywalled stories across India and Southeast Asia
  • Unlimited access to all premium subscriber newsletters
  • Visual Stories
  • Bonus annual gift subscription
  • Priority access to all new products and features

Rs. 8,474 /year

Subscribe
Or

Questions?

What kind of subscription plans do you offer?

We have three types of subscriptions
- Premium which gives you access to either the India or the Southeast Asia edition.
- Borderless which gives you complete access to The Ken across both editions
- Echelon which gives you complete access to The Ken across both editions along with a bonus gift subscription

What do I get if I subscribe?

The Premium edition gives you access to stories in that edition along with any five subscriber-only newsletters of your choice.

The Borderless and Echelon subscription gives you complete access to The Ken across editions and unlimited access to as many newsletters as you like.

What topics do you usually write about?

We publish sharp, original and reported stories on technology, business and healthcare. Our stories are forward-looking, analytical and directional — supported by data, visualisations and infographics. We use language and narrative that is accessible to even lay readers. And we optimise for quality over quantity, every single time.

Our specialised subscriber-only newsletters are written by our expert, award-winning journalists and cover a range of topics across finance, retail, clean energy, cryptocurrency, ed-tech and many more.

How many newsletters do you have?

We are constantly adding specialised subscriber-only newsletters all the time. All of these are written by our team of award-winning journalists on a specialised topic.

You can see the list of newsletters that we publish over here.

Does a Premium subscription to your Indian edition get me access to the Southeast Asia edition? Or vice-versa?

Afraid not. Each edition is separate with its own subscription plan. The India edition publishes stories focused on India. The Southeast Asia edition is focused on Southeast Asia. We may occasionally cross-publish stories from one edition to the other.

We recommend the Borderless or the Echelon Plan which will give you access to stories across both editions.

Do you have a mobile app?

Yes! We have a top-rated mobile app on both iOS and Android which allows you to read on-the-go and has some amazing features like the ability to bookmark stories, save on your device, dark mode, and much more. It’s really the best way to read The Ken.

Is there a free trial?

You can sign up for a free account to experience The Ken and understand our products better. We’ll send you some free stories and newsletters occasionally, and you can access our archive of previously published free stories. You can stay on the free account as long as you’d like.

The vast majority of our stories, articles and newsletters can be accessed only by a paid subscription.

Do you offer any discounts?

Sorry, no. Our journalism is funded completely by our subscribers. We believe that quality journalism comes at a price, and readers trust and pay us so that we can remain independent.

Do you offer refunds?

No. We allow you to sample our journalism for free before signing up, and after you do, we stand by its quality. But we do not offer refunds.

I am facing some trouble purchasing a subscription. What can I do?

Just write to us at [email protected] with details. We’ll help you out.

I have a few more questions. How can I reach out to you?

Sure. Just email us at [email protected] or follow us on Twitter.